146 related articles for article (PubMed ID: 6929188)
21. Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines.
Mini E; Moroson BA; Franco CT; Bertino JR
Cancer Res; 1985 Jan; 45(1):325-30. PubMed ID: 3855284
[TBL] [Abstract][Full Text] [Related]
22. Cancer research: from folate antagonism to molecular targets.
Bertino JR
Best Pract Res Clin Haematol; 2009 Dec; 22(4):577-82. PubMed ID: 19959110
[TBL] [Abstract][Full Text] [Related]
23. Conditional antifolate resistance in Bacillus subtilis thyA.
Farmer JL
Antimicrob Agents Chemother; 1979 Apr; 15(4):527-34. PubMed ID: 111614
[TBL] [Abstract][Full Text] [Related]
24. Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells.
Volpato JP; Mayotte N; Fossati E; Guerrero V; Sauvageau G; Pelletier JN
J Mol Recognit; 2011; 24(2):188-98. PubMed ID: 21360609
[TBL] [Abstract][Full Text] [Related]
25. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.
Pizzorno G; Moroson BA; Cashmore AR; Russello O; Mayer JR; Galivan J; Bunni MA; Priest DG; Beardsley GP
Cancer Res; 1995 Feb; 55(3):566-73. PubMed ID: 7834626
[TBL] [Abstract][Full Text] [Related]
26. Stabilization of dihydrofolate reductase by inhibitors in vivo and in vitro.
Hillcoat BL; Marshall L; Gauldie J; Hiebert M
Ann N Y Acad Sci; 1971 Nov; 186():187-208. PubMed ID: 4332034
[No Abstract] [Full Text] [Related]
27. Kinetic investigation of methotrexate resistant human dihydrofolate reductase (hDHFR) mutants at Phe31.
Chunduru SK; Appleman JR; Blakley RL
Adv Exp Med Biol; 1993; 338():507-10. PubMed ID: 8304168
[No Abstract] [Full Text] [Related]
28. The molecular perspective: methotrexate.
Goodsell DS
Stem Cells; 1999; 17(5):314-5. PubMed ID: 10527466
[No Abstract] [Full Text] [Related]
29. Biochemical mechanisms of resistance to antimetabolites.
Harrap KR; Jackson RC
Antibiot Chemother (1971); 1978; 23():228-37. PubMed ID: 348081
[No Abstract] [Full Text] [Related]
30. Molecular mechanisms of cellular resistance to folate analogs.
Grzelakowska-Sztabert B
Prog Clin Biol Res; 1983; 132C():213-22. PubMed ID: 6634773
[No Abstract] [Full Text] [Related]
31. Methotrexate inhibition of CCRF-CEM cultures of human lymphoblasts.
Roberts D; Warmath EV
Eur J Cancer (1965); 1975 Nov; 11(11):771-82. PubMed ID: 130240
[No Abstract] [Full Text] [Related]
32. Synthesis and evaluation of 2,4-diaminoquinazoline antifolates with activity against methotrexate-resistant human tumor cells.
Schornagel JH; Chang PK; Sciarini LJ; Moroson BA; Mini E; Cashmore AR; Bertino JR
Biochem Pharmacol; 1984 Oct; 33(20):3251-5. PubMed ID: 6487372
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of antifolate resistance and methotrexate efficacy in leukemia cells.
Fotoohi AK; Albertioni F
Leuk Lymphoma; 2008 Mar; 49(3):410-26. PubMed ID: 18297517
[TBL] [Abstract][Full Text] [Related]
34. Protection of CCRF-CEM human lymphoid cells from antifolates by retroviral gene transfer of variants of murine dihydrofolate reductase.
Mareya SM; Sorrentino BP; Blakley RL
Cancer Gene Ther; 1998; 5(4):225-35. PubMed ID: 9694074
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
Belur LR; James RI; May C; Diers MD; Swanson D; Gunther R; McIvor RS
J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
[TBL] [Abstract][Full Text] [Related]
36. Increased levels of folic acid reductase as a mechanism of resistance to amethopterin in leukemic cells.
FISCHER GA
Biochem Pharmacol; 1961 Jul; 7():75-7. PubMed ID: 13699838
[No Abstract] [Full Text] [Related]
37. 2-Substituted-mercapto-quinazolin-4(3H)-ones as DHFR Inhibitors.
El-Subbagh HI; Sabry MA
Mini Rev Med Chem; 2021; 21(16):2249-2260. PubMed ID: 33663366
[TBL] [Abstract][Full Text] [Related]
38. Acquired methotrexate resistance in lymphoblasts resulting from altered kinetic properties of dihydrofoltate reductase.
Jackson RC; Niethammer D
Eur J Cancer (1965); 1977 Jun; 13(6):567-75. PubMed ID: 880964
[No Abstract] [Full Text] [Related]
39. Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.
Domin BA; Cheng YC; Hakala MT
Mol Pharmacol; 1982 Jan; 21(1):231-8. PubMed ID: 7132960
[No Abstract] [Full Text] [Related]
40. Resistance of human tumor cell lines to antifolates.
Diddens H; Niethammer D; Jackson RC
Cancer Treat Rev; 1984 Mar; 11 Suppl A():37-41. PubMed ID: 6234060
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
